Exact Mass: 468.1551
Exact Mass Matches: 468.1551
Found 117 metabolites which its exact mass value is equals to given mass value 468.1551
,
within given mass tolerance error 0.01 dalton. Try search metabolite list with more accurate mass tolerance error
0.001 dalton.
Prim-O-glucosylcimifugin
Cimifugin 7-glucoside
PRIM-O-GLUCOSYLCIMIFUGIN is an organic heterotricyclic compound and an oxacycle. Prim-O-glucosylcimifugin is a natural product found in Ostericum grosseserratum, Saposhnikovia divaricata, and other organisms with data available. Prim-O-glucosylcimifugin exerts anti-inflammatory effects through the inhibition of iNOS and COX-2 expression by through regulating JAK2/STAT3 signaling. Prim-O-glucosylcimifugin exerts anti-inflammatory effects through the inhibition of iNOS and COX-2 expression by through regulating JAK2/STAT3 signaling.
dichamanetin
A natural product found in Piper sarmentosum.
threo-1-(4-hydroxy-2-methoxyphenyl)-2-(2,4-dihydroxy-phenyl)-1,3-propanediol-4-O-?-D-glucopyranoside
1,2-bis(4-hydroxy-3-methoxyphenyl)-1,3-propandiol 4-O-beta-D-glucopyranoside|1-(4-O-beta-glucosyl-2-hydroxyphenyl)-2-(2-hydroxy-4-methoxyphenyl)-1,3-propanediol|myriophylloside G|threo-1,2-bis(4-hydroxy-3-methoxyphenyl)-1,3-propandiol 4-O-beta-D-glucopyranoside|threo-2,3-bis(4-hydroxy-3-methoxyphenyl)-3-ethoxypropan-1-ol
6-O-(6?-O-phydroxybenzoyl)-beta-D-glucopyranosyl-des-p-hydroxybenzoyl-3-deoxycatalpin
Prim-O-glucosylcimifugin
Prim-O-glucosylcimifugin exerts anti-inflammatory effects through the inhibition of iNOS and COX-2 expression by through regulating JAK2/STAT3 signaling. Prim-O-glucosylcimifugin exerts anti-inflammatory effects through the inhibition of iNOS and COX-2 expression by through regulating JAK2/STAT3 signaling.
Cys Cys Phe Pro
Cys Cys Ile Met
Cys Cys Leu Met
Cys Cys Met Ile
Cys Cys Met Leu
Cys Cys Pro Phe
Cys Phe Cys Pro
Cys Phe Pro Cys
Cys Ile Cys Met
Cys Ile Met Cys
Cys Leu Cys Met
Cys Leu Met Cys
Cys Met Cys Ile
Cys Met Cys Leu
Cys Met Ile Cys
Cys Met Leu Cys
Cys Pro Cys Phe
Cys Pro Phe Cys
Asp Asp Gly Tyr
Asp Asp Tyr Gly
Asp Gly Asp Tyr
Asp Gly Tyr Asp
Asp Tyr Asp Gly
Asp Tyr Gly Asp
Phe Cys Cys Pro
Phe Cys Pro Cys
Phe Pro Cys Cys
Gly Asp Asp Tyr
Gly Asp Tyr Asp
Gly Met Met Met
Gly Tyr Asp Asp
Ile Cys Cys Met
Ile Cys Met Cys
Ile Met Cys Cys
Leu Cys Cys Met
Leu Cys Met Cys
Leu Met Cys Cys
Met Cys Cys Ile
Met Cys Cys Leu
Met Cys Ile Cys
Met Cys Leu Cys
Met Gly Met Met
Met Ile Cys Cys
Met Leu Cys Cys
Met Met Gly Met
Met Met Met Gly
Pro Cys Cys Phe
Pro Cys Phe Cys
Pro Phe Cys Cys
Tyr Asp Asp Gly
Tyr Asp Gly Asp
Tyr Gly Asp Asp
N-[(9H-Fluoren-9-ylmethoxy)carbonyl]glycylglycylglycylglycine
TERT-BUTYL2-(4-(PYRIDIN-2-YL)BENZYL)HYDRAZINECARBOXYLATE
(1R)-1-C-(4-Chloro-3-{4-[(3S)-tetrahydro-3-furanyloxy]benzyl}phenyl)-D-glucitol
Methyl 1-C-[4-chloro-3-[(4-ethoxyphenyl)methyl]phenyl]-5-C-(hydroxymethyl)-alpha-D-xylo-hexopyranoside
(r)-(+)-2-diphenylphosphino-2-methoxy-1,1-binaphthyl
1-[3-(3,5-Dinitrobenzoylamino)butyl]-2-methyl-1H-indole-3-carboxylic acid ethyl ester
5-hydroxy-4-(7-methoxy-1,1-dioxido-2H-1,2,4-benzothiadiazin-3-yl)-2-(3-methylbutyl)-6-phenylpyridazin-3(2H)-one
3-(2,5-dimethoxyphenyl)-6-[4-methoxy-3-(3-oxolanyloxy)phenyl]-7H-[1,2,4]triazolo[3,4-b][1,3,4]thiadiazine
2-amino-N-(3-ethoxypropyl)-1-(4-sulfamoylphenyl)-3-pyrrolo[3,2-b]quinoxalinecarboxamide
diethyl 5-[[2-(furan-2-carbonylamino)benzoyl]oxymethyl]-3-methyl-1H-pyrrole-2,4-dicarboxylate
[(3aS,4R,9bS)-1-(3-fluorophenyl)sulfonyl-8-(2-methoxyphenyl)-2,3,3a,4,5,9b-hexahydropyrrolo[3,2-c]quinolin-4-yl]methanol
[(3aR,4S,9bR)-1-(3-fluorophenyl)sulfonyl-8-(2-methoxyphenyl)-2,3,3a,4,5,9b-hexahydropyrrolo[3,2-c]quinolin-4-yl]methanol
2-(4-Hydroxyphenyl)ethyl 2,3,4,6-tetra-O-acetyl-alpha-(D)-glucopyranoside
SRT 2183
SRT 2183 is a selective Sirtuin-1 (SIRT1) activator with an EC1.5 value of 0.36 μM[1]. SRT 2183 induces growth arrest and apoptosis, concomitant with deacetylation of STAT3 and NF-κB, and reduction of c-Myc protein levels[2].
4-hydroxy-19-methoxy-2,15-dioxapentacyclo[22.2.2.1³,⁷.1¹⁰,¹⁴.0¹⁶,²¹]triaconta-1(26),3(30),4,6,10,12,14(29),16(21),18,24,27-undecaene-17,20-dione
(1s,4ar,5r,7s,7as)-7-hydroxy-7-methyl-1-{[(2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-1h,4ah,5h,6h,7ah-cyclopenta[c]pyran-5-yl 4-hydroxybenzoate
6-o-(4-hydroxybenzoyl)-ajugol
{"Ingredient_id": "HBIN012584","Ingredient_name": "6-o-(4-hydroxybenzoyl)-ajugol","Alias": "NA","Ingredient_formula": "C22H28O11","Ingredient_Smile": "CC1(CC(C2C1C(OC=C2)OC3C(C(C(C(O3)CO)O)O)O)OC(=O)C4=CC=C(C=C4)O)O","Ingredient_weight": "NA","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "9818","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "NA","DrugBank_id": "NA"}
6-O-p-hydroxybenzoylajugol
{"Ingredient_id": "HBIN012711","Ingredient_name": "6-O-p-hydroxybenzoylajugol","Alias": "AC1O3DGA; 6-o-p-hydroxybenzoyl ajugol; [(1S,4aR,7S,7aS)-7-hydroxy-7-methyl-1-[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-4a,5,6,7a-tetrahydro-1H-cyclopenta[c]pyran-5-yl] 4-hydroxybenzoate; 6-O-p-Hydroxybenzoyl ajugol","Ingredient_formula": "C22H28O11","Ingredient_Smile": "CC1(CC(C2C1C(OC=C2)OC3C(C(C(C(O3)CO)O)O)O)OC(=O)C4=CC=C(C=C4)O)O","Ingredient_weight": "468.4 g/mol","OB_score": "4.531761025","CAS_id": "NA","SymMap_id": "SMIT05758;SMIT06073;SMIT19243","TCMID_id": "31156","TCMSP_id": "MOL003728;MOL004098","TCM_ID_id": "NA","PubChem_id": "14396661","DrugBank_id": "NA"}